SUCCESSFUL TREATMENT OF BROWN NORWAY RAT MYELOCYTIC-LEUKEMIA (BNML) IN COMPLETE REMISSION (CR) WITH TIMED SEQUENTIAL CYTOSINE-ARABINOSIDE (ARA-C)

被引：0
|
作者：
VAUGHAN, WP [1 ]
BURKE, PJ [1 ]
机构：
[1] JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD 21205
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1980年 / 21卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：300 / 300
页数：1
相关论文
共 22 条
  • [1] CHEMOTHERAPY FOR ACUTE MYELOCYTIC-LEUKEMIA (AML) WITH CYTOSINE-ARABINOSIDE (ARA-C) AND ADRIAMYCIN (ADR)
    PREISLER, HD
    BJORNSSON, S
    HENDERSON, ES
    BLOOD, 1976, 48 (06) : 982 - 982
  • [2] CCNU PLUS CYTOSINE-ARABINOSIDE (ARA-C) TREATMENT OF ACUTE MYELOCYTIC LEUKEMIA COMPARED WITH THIOGUANINE (TG) PLUS ARA-C
    WALLACE, HJ
    HOAGLAND, HC
    ELLISON, RR
    GLIDEWELL, O
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1973, 14 (MAR): : 100 - +
  • [3] COMPARISON OF THE BIOLOGICAL AND PHARMACOLOGICAL EFFECT OF CYTOSINE-ARABINOSIDE (ARA-C) IN HUMAN AML AND A RAT LEUKEMIA MODEL (BNML)
    COLLY, LP
    ARENDSENHONDERS, MW
    EDELBROEK, P
    PETERS, WG
    WILLEMZE, R
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1985, 39 : 11 - 11
  • [4] TREATMENT OF REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA WITH PYRAZOFURIN (PZF) AND CYTOSINE-ARABINOSIDE (ARA-C)
    KAPLAN, H
    APPELBAUM, F
    CHEEVER, M
    WOOD, T
    GREENBERG, P
    EINSTEIN, A
    FEFER, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 168 - 168
  • [5] EFFECT OF HIGH-DOSE CYTOSINE-ARABINOSIDE (HD ARA-C) ON LEUKEMIC AND INTESTINAL-CELL KILL IN BROWN NORWAY MYELOID-LEUKEMIA (BNML) DEPENDS ON THE INTERVALS OF DRUG ADMINISTRATION
    COLLY, LP
    WILLEMZE, R
    FIBBE, WE
    VANROOD, JJ
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 461 - 461
  • [6] COMBINED EPIPODOPHYLLOTOXIN (VM26) AND CYTOSINE-ARABINOSIDE (ARA-C) FOR CONTINUING REMISSION OF ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
    KRANCE, R
    ROSEN, R
    ABILGAARD, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 158 - 158
  • [7] THE USE OF INTERMEDIATE DOSE CYTOSINE-ARABINOSIDE (ID ARA-C) IN THE TREATMENT OF ACUTE NON-LYMPHOCYTIC LEUKEMIA IN RELAPSE
    VANPROOIJEN, HC
    DEKKER, AW
    PUNT, K
    BRITISH JOURNAL OF HAEMATOLOGY, 1984, 57 (02) : 291 - 299
  • [8] CELL KINETIC-STUDIES AFTER HIGH-DOSE ARA-C AND ADRIAMYCIN TREATMENT IN A SLOWLY GROWING-RAT LEUKEMIA MODEL (BNML) FOR HUMAN ACUTE MYELOCYTIC-LEUKEMIA
    COLLY, LP
    VANBEKKUM, DW
    HAGENBEEK, A
    LEUKEMIA RESEARCH, 1984, 8 (06) : 945 - 952
  • [9] TREATMENT OF REFRACTORY ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - COMBINATION CHEMOTHERAPY WITH VM26 AND CYTOSINE-ARABINOSIDE (ARA-C)
    RIVERA, G
    AUR, RJ
    VERZOSA, M
    AVERY, T
    PRATT, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 285 - 285
  • [10] HIGH-DOSE (HD) CYTOSINE-ARABINOSIDE (ARA-C) FOR THE TREATMENT OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOGENOUS LEUKEMIA (AML)
    HERZIG, GP
    WOLFF, SN
    HERZIG, RH
    STEIN, RS
    LAZARUS, HM
    MARION, JM
    SPTIZER, TR
    FLEXNER, JM
    PHILLIPS, GL
    LEUKEMIA RESEARCH, 1986, 10 (01) : 87 - 87
123